This book provides a concise overview over the pathology of retinal angiogenic diseases and
explains why anti-angiogenic therapy is effective in so many patients. The reader is guided
through the various clinical indications for anti-angiogenic therapy and made aware of its
merits as well as current challenges and limitations. It is explained how since its
introduction for the treatment of exudative age-related macular degeneration in 2006
anti-angiogenic therapy has revolutionized the way in which we treat a range of ocular
diseases. All of the authors are established experts in their respective fields who share their
extensive knowledge and clinical experience with the reader. This book is both a valuable
introduction to anti-angiogenic therapy in ophthalmology and a day-to-day companion for all
ophthalmologists seeing patients with some of the most prevalent retinal diseases.
